Objectives Thrombocytopenia, a frequent clinical manifestation in patients with APS, could
be an independent predictor of recurrent thrombotic, obstetric and severe extracriteria …

Antiphospholipid antibodies (aPL) are both laboratory evidence and causative factors for a
broad spectrum of clinical manifestations of antiphospholipid syndrome (APS), with …

Background Interstitial lung disease (ILD) is a relatively prevalent extra-articular
manifestation of rheumatoid arthritis (RA) and contributes to significant morbidity and …

Antiphospholipid antibodies in patients with antiphospholipid syndrome Skoči na glavni sadržaj
english Prijava i registracija Prijava Promjena načina autentikacije Registracija srce logo …

Objectives To validate the performance of the adjusted global antiphospholipid syndrome
(APS) score (aGAPSS), Padua score and Caprini score to predict thrombosis recurrence in …

Introduction Microvascular manifestations constitute a subtype of antiphospholipid
syndrome, and those patients have relatively poor prognoses, so it is important to find …

We sought to determine the prevalence of antiphospholipid antibodies (aPLs) and their
correlation with COVID-19 severity (in terms of clinical and laboratory parameters) in …

Objective To evaluate a novel fully automated immunoturbidimetric assay developed by
Qiangsheng Biotechnology Company for the detection of anticyclic citrullinated peptide …

Introduction Antiphospholipid syndrome (APS) is an autoimmune disorder associated with
thrombosis and adverse obstetric outcomes. Early diagnosis and intervention can improve …

Background Anti-β2GPI-domain I (β2GPI-DI) antibody is pathogenic in patients with
antiphospholipid syndrome (APS), but its additional clinical associations and diagnostic …